Chao Li

Chao Li

Auto-generated profile, based on publicly available information

Chao Li

Division of Gastroenterology, The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong Province China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
RCRirong Chen
Rirong Chen
LLLi Li
Li Li
CLChao Li
Chao Li
YSYuhan Su
Yuhan Su
YZYingfan Zhang
Yingfan Zhang
Shenghong ZhangShenghong Zhang
Shenghong Zhang
Objective: Endoscopic remission is the primary therapeutic target and associated with clinical outcome in Crohn’s disease (CD). Non-invasive and accurate biomarkers are important in monitoring endoscopic remission frequently. Our study aimed at investigating the predictive capacity of prealbumin and retinol-binding protein 4 (RBP4) for identifying endoscopic remission. Methods: From June 2018 to December 2020, 515 endoscopy procedures (332 in the training cohort and 183 in the validation cohort) were enrolled in this multicentre retrospective cohort study. Blood samples were collected for prealbumin or RBP4 testing with 7 days before the endoscopy. A simple Endoscopic Score for CD (SES-CD) was performed to evaluate endoscopic activity and defined endoscopic remission. The area under receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value and negative predictive value were performed to assess the predictive capacity of the biomarkers. Results: Serum concentration of prealbumin and RBP4 was demonstrated to be higher in patients with endoscopic remission and significantly negatively correlated with SES-CD in the training cohort. The AUROC of prealbumin and specificity of prealbumin and RBP4 were larger than that of C-reactive protein in the training cohort and the validation cohort. The model combining prealbumin and faecal calprotectin had the largest AUROC (0.842 [95% CI: 0.775– 0.908]). Furthermore, in both cohorts, prealbumin had a larger AUROC than C-reactive protein for identifying endoscopic remission in patients with anti-tumour necrosis factor therapy. Conclusion: Prealbumin and RBP4 were promising biomarkers for identifying endoscopic remission, especially in patients with anti-tumour necrosis factor therapy.

1 September 2021 in Asian Journal of Surgery
Verified
Journal Article
Open access
JWJie Wu
Jie Wu
CLChao Li
Chao Li

2 July 2025 in Journal of Digestive Diseases
Verified
Journal Article
Closed access
CLChao Li
Chao Li
XZXi Zhang
Xi Zhang
JZJie Qi Zheng
Jie Qi Zheng
YTYi Zhe Tie
Yi Zhe Tie
ZZZhi Rong Zeng
Zhi Rong Zeng
SZSheng Hong Zhang
Sheng Hong Zhang